Free Trial
NYSE:PRGO

Perrigo (PRGO) Stock Price, News & Analysis

Perrigo logo
$16.16 -0.08 (-0.46%)
Closing price 03:59 PM Eastern
Extended Trading
$16.18 +0.02 (+0.12%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Perrigo Stock (NYSE:PRGO)

Advanced

Key Stats

Today's Range
$16.07
▼
$16.67
50-Day Range
$13.47
▼
$16.99
52-Week Range
$9.23
▼
$17.02
Volume
852,308 shs
Average Volume
3.00 million shs
Market Capitalization
$2.24 billion
P/E Ratio
N/A
Dividend Yield
7.18%
Price Target
$18.50
Consensus Rating
Reduce

Company Overview

Perrigo is a global consumer healthcare company that develops, manufactures and markets over-the-counter medicines and other self-care products. Its offerings include treatments for allergies, coughs and colds, pain and digestive health, as well as skin care, oral care and infant nutrition products.

The company supplies both its own consumer brands and store-brand products, which retailers sell under their own labels. Perrigo serves customers primarily in North America and Europe through retail and other healthcare channels.

Perrigo traces its roots to a general store opened in Allegan, Michigan, in 1887, where it began supplying medicines. The company is now headquartered in Dublin, Ireland.

AI Generated. May Contain Errors.

Perrigo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

PRGO MarketRank™: 
2.022941254475 of 5 stars

Perrigo scored higher than 40% of companies evaluated by MarketBeat, and ranked 709th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Perrigo has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 2 sell ratings.

  • Upside Potential

    Perrigo has a consensus price target of $18.50, representing about 14.3% upside from its current price of $16.18.

  • Amount of Analyst Coverage

    Perrigo has only been the subject of 3 research reports in the past 90 days.

  • Read more about Perrigo's stock forecast and price target.
  • Earnings Growth

    Earnings for Perrigo are expected to decrease by -4.72% in the coming year, from $2.33 to $2.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Perrigo has a PEG Ratio of 1.75. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Perrigo has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    17.80% of the float of Perrigo has been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 11.34, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Perrigo has recently increased by 1.79%, indicating that investor sentiment is decreasing.
  • Dividend Leadership

    Perrigo is a leading dividend payer. It pays a dividend yield of 7.17%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Perrigo has been increasing its dividend for 23 years.

  • Dividend Sustainability

    Based on earnings estimates, Perrigo will have a dividend payout ratio of 52.25% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

  • Read more about Perrigo's dividend.
  • News Sentiment

    Perrigo has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Perrigo this week, compared to 8 articles on an average week.
  • Search Interest

    16 people have searched for PRGO on MarketBeat in the last 30 days. This is an increase of 129% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Perrigo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.40% of the stock of Perrigo is held by insiders.

  • Percentage Held by Institutions

    95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Perrigo's insider trading history.
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRGO Stock News Headlines

Perrigo Earnings Call Shows Progress Amid Pressure
Buy Stocks… A Crash is Coming
Think stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.tc pixel
Perrigo to Attend the Jefferies Miami Consumer Conference
See More Headlines

PRGO Stock Analysis - Frequently Asked Questions

Perrigo's stock was trading at $13.92 at the start of the year. Since then, PRGO shares have increased by 16.3% and is now trading at $16.1840.

Perrigo Company plc (NYSE:PRGO) issued its quarterly earnings data on Wednesday, November, 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.51 by $0.09. The firm's revenue for the quarter was down 5.2% on a year-over-year basis.
Read the conference call transcript
.

Perrigo subsidiaries include these companies: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and others.

Perrigo's top institutional shareholders include State Street Corp (6.22%), Edmond DE Rothschild Holding S.A. (1.72%), Sound Income Strategies LLC (1.16%) and Gamco Investors INC. ET AL (0.90%). Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Patrick Lockwood-Taylor, Geoffrey M Parker, Alison Ives, Katherine C Doyle and Abigail Lennox.
View institutional ownership trends
.

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Pfizer (PFE), Tesla (TSLA), Intel (INTC) and SLB (SLB).

Company Calendar

Record date for 9/15 Dividend
8/28/2026
Ex-Dividend for 9/15 Dividend
8/28/2026
Dividend Payable
9/15/2026
Last Earnings
11/04/2026
Today
11/16/2026
Record date for 12/15 Dividend
11/27/2026
Ex-Dividend for 12/15 Dividend
11/27/2026
Dividend Payable
12/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PRGO
CIK
1585364
Employees
8,100
Year Founded
1887

Price Target and Rating

High Price Target
$19.00
Low Price Target
$18.00
Potential Upside/Downside
+13.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($12.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.32
P/E Growth
1.75
Net Income
-$1.43 billion
Net Margins
-43.27%
Pretax Margin
-40.41%
Return on Equity
12.39%
Return on Assets
4.07%

Debt

Debt-to-Equity Ratio
1.35
Current Ratio
2.35
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$4.09 billion
Price / Sales
0.55
Cash Flow
$5.29 per share
Price / Cash Flow
3.07
Book Value
$21.33 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
138,802,000
Free Float
138,247,000
Market Cap
$2.25 billion
Optionable
Optionable
Beta
0.71

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NYSE:PRGO) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners